Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fishbane

Showing results (141-150 of 357) with videos related to

Pageof 36
Sort By:
Seminars in Dialysis|June 15, 2013
How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The use of iron supplementation to reduce ESA dosing in hemodialysisShayan Shirazian, Candace Grant, Ilene Miller, et al.
Clinical Kidney Journal|May 8, 2023
Hypoxia-inducible factor stabilizers: 27 228 patients studied, yet a role still undefinedSteven Fishbane, Deepa A Malieckal, Ji H Ng
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 1999
Is there material hazard to treatment with intravenous iron?S Fishbane, J K Maesaka, S K Mittal
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1995
The effect of KT/V(urea) on nitrogen appearance and appetite in peritoneal dialysisR I Lynn, S Fishbane, N S Ginsberg
The Annals of Pharmacotherapy|October 15, 2009
Meeting new challenges in the management of anemia of chronic kidney disease through collaborative care with pharmacistsShaffeeulah Bacchus, Neeta O'Mara, Harold Manley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1996
Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patientsJ C Ruggian, J K Maesaka, S Fishbane
The New England Journal of Medicine|April 19, 2013
Peginesatide for anemia in chronic kidney diseaseIain C Macdougall, Steven Fishbane, Anne-Marie Duliege
Seminars in Nephrology|May 29, 2016
Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing HemodialysisHitesh H Shah, Azzour D Hazzan, Steven Fishbane
Seminars in Oncology|June 1, 1997
Paraneoplastic syndromes of the kidneyJ K Maesaka, S K Mittal, S Fishbane
Current Opinion in Nephrology and Hypertension|June 8, 2015
Novel iron-based phosphate binders in patients with chronic kidney diseaseHitesh H Shah, Azzour D Hazzan, Steven Fishbane
Pageof 36

Showing results (141-150 of 357) with videos related to

Sort By:
Pageof 36
Seminars in Dialysis|June 15, 2013
How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The use of iron supplementation to reduce ESA dosing in hemodialysisShayan Shirazian, Candace Grant, Ilene Miller, et al.
Clinical Kidney Journal|May 8, 2023
Hypoxia-inducible factor stabilizers: 27 228 patients studied, yet a role still undefinedSteven Fishbane, Deepa A Malieckal, Ji H Ng
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 27, 1999
Is there material hazard to treatment with intravenous iron?S Fishbane, J K Maesaka, S K Mittal
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1995
The effect of KT/V(urea) on nitrogen appearance and appetite in peritoneal dialysisR I Lynn, S Fishbane, N S Ginsberg
The Annals of Pharmacotherapy|October 15, 2009
Meeting new challenges in the management of anemia of chronic kidney disease through collaborative care with pharmacistsShaffeeulah Bacchus, Neeta O'Mara, Harold Manley, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 1, 1996
Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patientsJ C Ruggian, J K Maesaka, S Fishbane
The New England Journal of Medicine|April 19, 2013
Peginesatide for anemia in chronic kidney diseaseIain C Macdougall, Steven Fishbane, Anne-Marie Duliege
Seminars in Nephrology|May 29, 2016
Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing HemodialysisHitesh H Shah, Azzour D Hazzan, Steven Fishbane
Seminars in Oncology|June 1, 1997
Paraneoplastic syndromes of the kidneyJ K Maesaka, S K Mittal, S Fishbane
Current Opinion in Nephrology and Hypertension|June 8, 2015
Novel iron-based phosphate binders in patients with chronic kidney diseaseHitesh H Shah, Azzour D Hazzan, Steven Fishbane
Pageof 36